360 related articles for article (PubMed ID: 16883001)
1. Imaging prostate cancer with 11C-choline PET/CT.
Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
[TBL] [Abstract][Full Text] [Related]
2. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
[TBL] [Abstract][Full Text] [Related]
4. Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
Incerti E; Fodor A; Mapelli P; Fiorino C; Alongi P; Kirienko M; Giovacchini G; Busnardo E; Gianolli L; Di Muzio N; Picchio M
J Nucl Med; 2015 Dec; 56(12):1836-42. PubMed ID: 26405166
[TBL] [Abstract][Full Text] [Related]
5. The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.
Souvatzoglou M; Weirich G; Schwarzenboeck S; Maurer T; Schuster T; Bundschuh RA; Eiber M; Herrmann K; Kuebler H; Wester HJ; Hoefler H; Gschwend J; Schwaiger M; Treiber U; Krause BJ
Clin Cancer Res; 2011 Jun; 17(11):3751-9. PubMed ID: 21493868
[TBL] [Abstract][Full Text] [Related]
6. C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions.
Li X; Liu Q; Wang M; Jin X; Liu Q; Yao S; Liu S; Li J
Clin Nucl Med; 2008 Oct; 33(10):671-6. PubMed ID: 18806565
[TBL] [Abstract][Full Text] [Related]
7. 11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.
Giovacchini G; Picchio M; Garcia-Parra R; Briganti A; Abdollah F; Gianolli L; Schindler C; Montorsi F; Messa C; Fazio F
J Nucl Med; 2014 Feb; 55(2):233-41. PubMed ID: 24408897
[TBL] [Abstract][Full Text] [Related]
8. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
Testa C; Schiavina R; Lodi R; Salizzoni E; Corti B; Farsad M; Kurhanewicz J; Manferrari F; Brunocilla E; Tonon C; Monetti N; Castellucci P; Fanti S; Coe M; Grigioni WF; Martorana G; Canini R; Barbiroli B
Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
[TBL] [Abstract][Full Text] [Related]
10. 11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.
Garcia JR; Jorcano S; Soler M; Linero D; Moragas M; Riera E; Miralbell R; Lomeña F
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):342-50. PubMed ID: 24844254
[TBL] [Abstract][Full Text] [Related]
11. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
Castellucci P; Fuccio C; Nanni C; Santi I; Rizzello A; Lodi F; Franceschelli A; Martorana G; Manferrari F; Fanti S
J Nucl Med; 2009 Sep; 50(9):1394-400. PubMed ID: 19690023
[TBL] [Abstract][Full Text] [Related]
12. Role of
Jiménez Londoño GA; García Vicente AM; Amo-Salas M; Fúnez Mayorga F; López Guerrero MA; Talavera Rubio MP; Gutierrez Martin P; González García B; de la Torre Pérez JA; Soriano Castrejón ÁM
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):241-246. PubMed ID: 28330596
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy.
Giovacchini G; Picchio M; Parra RG; Briganti A; Gianolli L; Montorsi F; Messa C
Clin Nucl Med; 2012 Apr; 37(4):325-31. PubMed ID: 22391699
[TBL] [Abstract][Full Text] [Related]
14. Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer.
Scher B; Seitz M; Albinger W; Tiling R; Scherr M; Becker HC; Souvatzogluou M; Gildehaus FJ; Wester HJ; Dresel S
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):45-53. PubMed ID: 16932935
[TBL] [Abstract][Full Text] [Related]
15. Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma.
Hernández-Argüello M; Quiceno H; Pascual I; Solorzano JL; Benito A; Collantes M; Rodríguez-Fraile M; Pardo J; Richter JA
Prostate; 2016 Jan; 76(1):3-12. PubMed ID: 26390847
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
Sutinen E; Nurmi M; Roivainen A; Varpula M; Tolvanen T; Lehikoinen P; Minn H
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):317-24. PubMed ID: 14628097
[TBL] [Abstract][Full Text] [Related]
17. [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
Reske SN; Blumstein NM; Glatting G
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):9-17. PubMed ID: 17828534
[TBL] [Abstract][Full Text] [Related]
18. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis.
Farsad M; Schiavina R; Castellucci P; Nanni C; Corti B; Martorana G; Canini R; Grigioni W; Boschi S; Marengo M; Pettinato C; Salizzoni E; Monetti N; Franchi R; Fanti S
J Nucl Med; 2005 Oct; 46(10):1642-9. PubMed ID: 16204714
[TBL] [Abstract][Full Text] [Related]
19. Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.
Vag T; Heck MM; Beer AJ; Souvatzoglou M; Weirich G; Holzapfel K; Rummeny EJ; Schwaiger M; Krause BJ; Eiber M
Eur Radiol; 2014 Aug; 24(8):1821-6. PubMed ID: 24889997
[TBL] [Abstract][Full Text] [Related]
20. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
Schiavina R; Scattoni V; Castellucci P; Picchio M; Corti B; Briganti A; Franceschelli A; Sanguedolce F; Bertaccini A; Farsad M; Giovacchini G; Fanti S; Grigioni WF; Fazio F; Montorsi F; Rigatti P; Martorana G
Eur Urol; 2008 Aug; 54(2):392-401. PubMed ID: 18456393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
